Surgical Tourniquets Market Size, Share, Growth and Forecast (2026 - 2036)

Surgical Tourniquets Market Forecast and Outlook (2026 to 2036)

• In 2025, the surgical tourniquets market surpassed a value of USD 0.7 billion.
• Based on Fact.MR analysis, demand for surgical tourniquets is estimated to grow to USD 0.8 billion in 2026 and USD 1.9 billion by 2036.
• FACT.MR projects a CAGR of 9.8% during the forecast period.
• The market is projected to add USD 1.2 billion in absolute value through 2036, reflecting steady structural expansion instead of cyclical fluctuation.
• Rising orthopedic surgery volumes, aging population demographics, and tightening infection control mandates across hospital networks are sustaining consistent demand growth.
• Pricing pressure from group purchasing organizations limits margin improvement. Reimbursement constraints in established healthcare systems add another barrier.

Summary of surgical tourniquets market

• Demand Drivers
  • Orthopedic surgeons and operating room administrators at tertiary hospitals are increasing tourniquet adoption as total knee arthroplasty and joint replacement procedure volumes rise globally, driven by aging population demographics and higher rates of osteoarthritis diagnosis.
  • Hospital infection control committees are increasing use of single use disposable tourniquet cuffs as healthcare-associated infection prevention protocols tighten under national accreditation requirements and CMS hospital quality reporting mandates.
  • Ambulatory surgical center administrators and outpatient orthopedic clinic directors are increasing capital investment in automated electronic tourniquet consoles to meet regulatory safety standards and reduce manual pressure management errors across high-frequency procedure schedules.
• Key Segments Analyzed
  • By Application: Knee arthroplasty holds 41% share in 2026 due to rising orthopedic joint replacement procedures and growing demand for controlled blood flow management during surgery.
  • By Product: Tourniquet systems account for 52% share in 2026 due to increasing adoption of automated pressure control systems across surgical departments.
  • By End User: Hospitals hold 58% share in 2026 due to high surgical procedure volumes and wider availability of advanced operating room infrastructure.
  • By Technology: Pneumatic tourniquet systems hold 49% share in 2026 due to precise pressure regulation and strong adoption across orthopedic surgery centers.
  • By Cuff Type: Disposable cuffs account for 54% share in 2026 due to stricter infection prevention standards and rising preference for single-use surgical products.
  • By Geography: South Korea expands at 4.5% CAGR through 2036 due to rising orthopedic procedure volumes and increasing adoption of automated surgical systems.
• Analyst Opinion at FACT.MR
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, opines, CXOs will find that infection control standards and operating room automation investment are major factors influencing disposable cuff and electronic tourniquet adoption. Companies securing early hospital contracts and disposable platform approvals are strengthening recurring revenue across orthopedic surgical networks.
• Strategic Implications
  • Tourniquet manufacturers should pursue product development across pneumatic and automated electronic platforms. Compatibility with existing pressure management systems can help orthopedic departments upgrade infrastructure with less disruption.
  • Surgical device distributors expanding across South Korea and Germany through hospital buying group agreements can access reimbursement linked replacement cycles. Such agreements can reduce account entry costs.
  • Investing in proprietary disposable cuff systems compatible with multiple console platforms reduces switching costs for hospital operating room administrators. Recurring cuff use supports consumable revenue across multiyear supply agreements.

The United States is projected to expand at 4.3% CAGR through 2036 as Centers for Medicare and Medicaid Services reimbursement frameworks supporting outpatient orthopedic surgical volume growth. Germany is forecast to grow at 4.4% CAGR as DRG-based hospital funding structures support capital investment in automated tourniquet systems across orthopedic departments. France is projected to expand at 4.2% CAGR as national health insurance coverage for ambulatory surgical procedures increases tourniquet utilization across outpatient orthopedic centers. South Korea is expected to record a 4.5% CAGR, reflecting the fastest growth among covered countries, as the National Health Insurance Service expands orthopedic reimbursement coverage and domestic manufacturers invest in automated surgical tourniquet platforms. The United Kingdom is forecast to grow at 4.1% CAGR as NHS surgical volume recovery post-2022 backlog clearance supports steady tourniquet replacement and upgrade cycles. Italy is projected to expand at 4.1% CAGR through 2036 as regional health authorities increase capital spending on surgical infrastructure to reduce procedural delays across public hospital orthopedic units.

Segmental Analysis

Surgical Tourniquets Market Analysis by Application

Knee arthroplasty will hold 41% share in 2026 due to rising orthopedic joint replacement procedures and growing demand for controlled blood flow management during surgery. Orthopedic surgeons increasingly rely on tourniquet systems to maintain a clear surgical field during implant procedures.

• Strong Joint Replacement Demand: Rising knee replacement procedures supporting stable tourniquet utilization across orthopedic hospitals.
• Growth in Trauma Surgery: Emergency limb surgery procedures are increasing adoption of tourniquet systems across trauma care centers.
• Zimmer Biomet Acquires Paragon 28 to Expand Orthopedic Surgical Platform Portfolio: Zimmer Biomet strengthened its orthopedic surgical platform portfolio in 2025 through the acquisition of Paragon 28. The deal expanded the company’s surgical equipment and extremity procedure capabilities across hospital orthopedic departments. 

Surgical Tourniquets Market Analysis by Product

Tourniquet systems will project 52% share in 2026 because automated pressure management consoles are gaining use. Hospitals are increasingly replacing manual systems with standardized electronic and pneumatic platforms.

• Operating Room Standardization: Hospitals are increasing deployment of automated tourniquet systems across orthopedic surgical suites.
• Growth in Multi-Platform Compatibility: Manufacturers are expanding cuff compatibility across different surgical console systems.
• Healthcare Holding Schweiz AG Acquires PlusORTHO Prothetik: Healthcare Holding Schweiz AG completed the acquisition of PlusORTHO Prothetik GmbH in January 2026 to strengthen its orthopedic surgical product portfolio across European healthcare markets. The acquisition expanded the company’s position in orthopedic operating room and surgical support equipment segments. 

Surgical Tourniquets Market Analysis by End User

FACT.MR analysis estimates that hospitals will hold for 58% share in 2026 due to high inpatient surgical procedure volumes and advanced operating room infrastructure availability. Major healthcare systems are investing investment in multi-console surgical environments.

• Strong Hospital Activity: Hospital networks are strengthening long-term tourniquet system purchasing agreements.
• Expansion of Ambulatory Centers: Outpatient orthopedic centers are increasing automated tourniquet adoption.
• Growth in Specialty Clinics: Orthopedic specialty clinics are increasing dedicated tourniquet system installations.

Surgical Tourniquets Market Analysis by Technology

Pneumatic tourniquet systems will hold 49% share in 2026 because precise pressure regulation and strong clinical adoption history across orthopedic surgery departments. Hospitals continue preferring pneumatic systems for reliability and compatibility with existing surgical infrastructure.

• High Clinical Reliability: Pneumatic systems maintain strong preference across major orthopedic hospitals.
• Rising Electronic System Adoption: Hospitals are evaluating next-generation automated electronic tourniquet systems.
• Golden Hour Medical Expands AutoTQ Automatic Tourniquet Deployment: Golden Hour Medical accelerated commercial deployment of its AutoTQ automatic tourniquet platform during 2026 across hospitals and emergency response systems. The FDA-registered device uses automated pressure application and guided instructions to improve trauma bleeding control response. 

Surgical Tourniquets Market Analysis by Cuff Type

Disposable cuffs will account for 54% share in 2026 due to stronger infection prevention standards and increasing preference for single-use surgical products. Hospitals are progressively replacing reusable cuff inventories across high-volume orthopedic operating rooms.

• Strong Disposable Product Adoption: Hospitals are increasing single-use cuff deployment to reduce infection risks.
• Continued Reusable Cuff Presence: Some healthcare systems using reusable cuffs where sterilization infrastructure remains cost-efficient.
• Expansion of Universal-fit Cuffs: Manufacturers are developing disposable cuffs compatible with multiple console systems.

Drivers, Restraints, and Opportunities

FACT.MR analysis indicates that the surgical tourniquets market is growing steadily due to rising orthopedic surgery volumes and stricter hospital infection control standards. Hospitals and ambulatory surgical centers are adopting automated and disposable tourniquet systems to improve operating room efficiency and reduce contamination risks. Standardized surgical workflows support replacement of older manual systems with automated pressure controlled platforms.

Healthcare facilities are prioritizing patient safety and infection prevention across busy orthopedic and trauma surgery departments. Disposable cuff adoption is rising as hospitals seek to reduce sterilization workload and minimize contamination exposure between procedures.

• Rising Orthopedic Surgery Volumes: Growing knee replacement and trauma surgery procedures are increasing demand for advanced tourniquet systems across orthopedic operating rooms.
• Stronger Infection Control Standards: Hospitals are increasing adoption of disposable tourniquet cuffs to reduce contamination risk and support compliance requirements.
• Expansion of Ambulatory Surgical Centers: Rising outpatient orthopedic procedures are strengthening demand for compact and automated tourniquet systems.

Regional Analysis

The surgical tourniquets market is assessed across North America, Europe, Asia Pacific, Latin America, and Middle East and Africa covering 40+ countries segmented by healthcare infrastructure maturity, surgical procedure volume growth, reimbursement environment, and infection control regulatory frameworks. The full report offers market attractiveness analysis by region and country.

Source: Fact.MR (FACT.MR) analysis, based on proprietary forecasting model and primary research

North America Surgical Tourniquets Market Analysis

North America is a commercially developed surgical tourniquet market due to strong hospital infrastructure and expanding outpatient orthopedic surgery activity. Hospitals and ambulatory surgical centers are increasing investment in automated tourniquet systems and disposable cuffs to improve operating room efficiency and infection prevention compliance.

• United States: The United States remains the largest market for surgical tourniquets in North America. The market is projected to grow at 4.3% CAGR by 2036. Rising outpatient knee replacement procedures are increasing demand for advanced pneumatic and automated tourniquet systems across ambulatory surgical centers. Hospitals are adopting disposable cuffs to strengthen infection prevention protocols and reduce sterilization workload across orthopedic departments.

FACT.MR's North America analysis covers the United States, Canada, and Mexico. Readers can find outpatient orthopedic procedure trends, disposable cuff adoption benchmarks, and ambulatory surgical center investment analysis by country.

Europe Surgical Tourniquets Market Analysis

Europe is a regulation guided surgical tourniquet market supported by hospital modernization activity and stricter medical device technology standards. Hospitals across the region are increasing replacement of older reusable systems with disposable and automated tourniquet platforms.

• Germany: Germany is one of the leading European surgical tourniquet markets due to strong orthopedic surgery infrastructure and hospital equipment investment activity. The market is projected to expand at 4.4% CAGR by 2036. Hospitals are increasing adoption of MDR-compliant disposable cuffs and automated surgical systems to strengthen operating room safety standards. Rising joint replacement procedure volumes are supporting stable tourniquet demand across orthopedic departments.
• France: France witnesses stable surgical tourniquet demand expanding ambulatory orthopedic surgery programs. The market is projected to grow at 4.2% CAGR by 2036. Hospitals and private surgical centers are increasing investment in operating room equipment modernization and disposable surgical products. Rising outpatient orthopedic procedure activity is strengthening tourniquet system utilization.
• United Kingdom: The United Kingdom maintains steady surgical tourniquet demand due to growing orthopedic procedure recovery activity across NHS hospital systems. The market is projected to expand at 4.1% CAGR till 2036. Hospitals are increasing disposable cuff and upgrading automated tourniquet systems to support surgical throughput.

• Italy: Italy is experiencing gradual growth in surgical tourniquet demand due to expanding hospital modernization investment and orthopedic infrastructure upgrades. The market is forecast to expand at 4.1% CAGR by 2036. Public hospitals are increasing replacement of aging surgical equipment and strengthening long-term agreements for automated tourniquet platforms. Growing orthopedic surgery volumes are supporting disposable cuff adoption.

FACT.MR's Europe analysis covers Germany, the United Kingdom, France, Italy, Spain, Nordic Countries, BENELUX, and Rest of Western Europe. Readers can find MDR compliance trends, hospital equipment investment analysis, and disposable cuff adoption benchmarks by country.

Asia Pacific Surgical Tourniquets Market Analysis

Asia Pacific shows faster regional growth as orthopedic surgery infrastructure investment and expanding healthcare coverage for joint replacement procedures. Hospitals across the region are increasing of automated surgical systems and disposable tourniquet products. Domestic medical device manufacturing expansion is strengthening regional supply chain capability.

• South Korea: South Korea represents the fastest-growing surgical tourniquet market among major countries covered in the study. The market is projected to rise at 4.5% CAGR across 2036. Expanding reimbursement support for orthopedic procedures is increasing demand for automated tourniquet systems across specialty hospitals. Domestic medical device manufacturers are also strengthening local production of advanced surgical tourniquet platforms and disposable cuffs.

FACT.MR's Asia Pacific analysis covers China, India, Japan, ASEAN, South Korea, and Australia and New Zealand. Readers can find reimbursement expansion trends, orthopedic procedure forecasts, and domestic medical device manufacturing benchmarks by country.

Competitive Aligners for Market Players

Surgical tourniquet manufacturers compete through infection control compliance capability and automated pressure management technology. Long term hospital supply agreements are major competitive factors. Companies with disposable cuff portfolios and automated console systems hold better positions across orthopedic surgery networks and ambulatory surgical centers. Regulatory compliance requirements and operating room safety standards influence sourcing decisions across hospital systems.

Manufacturers are investing in disposable cuff development to support stricter infection prevention standards. Hospitals are replacing reusable cuff inventories with single use platforms to reduce sterilization workload and contamination risk. Disposable cuff conversion creates stable recurring revenue opportunities for suppliers with broad disposable product portfolios. Automated electronic and pneumatic tourniquet systems are becoming major competitive differentiators across the market. Hospitals prefer systems with real time pressure monitoring and standardized operating capability to improve surgical workflow consistency. Companies offering multi platform cuff compatibility are gaining wider acceptance across healthcare systems using mixed surgical equipment environments.

Long term agreements with hospital networks and buying groups are important for revenue stability. Major suppliers with established orthopedic surgery relationships can gain share through bundled operating room equipment programs. Expanding ambulatory surgical center activity increases demand for compact and cost efficient automated tourniquet systems designed for outpatient orthopedic procedures.

Key Players

• Zimmer Biomet
• Stryker Corporation
• Delfi Medical Innovations
• OHK Medical Devices
• Anetic Aid
• VBM Medizintechnik
• Ulrich Medical
• Hammarplast Medical

Bibliography

• [1] Zimmer Biomet Holdings, Inc. (2025). Zimmer Biomet announces acquisition of Paragon 28.
• [2] Healthcare Holding Schweiz AG. (2026). Healthcare Holding Schweiz acquires PlusORTHO Prothetik GmbH.
• [3] Business Insider. (2026). Golden Hour Medical expands AutoTQ automatic tourniquet deployment for trauma response systems.
• [4] Aflatooni, J., Goble, H., Lambert, B., Liberman, S., & McCulloch, P. C. (2025). Limb occlusion pressure versus standard pneumatic tourniquet pressure in anterior cruciate ligament surgery: A randomized controlled trial. Journal of the American Academy of Orthopaedic Surgeons Global Research & Reviews, 9(5), e24.00282.
• [5] Montreuil, J., Tanzer, M., Zhang, Y. L., Rajda, E., Avizonis, D., & Hart, A. (2024). Tourniquet use and local tissue concentrations of cefazolin during total knee arthroplasty: A randomized clinical trial. JAMA Network Open, 7(8), e2429702.

This Report Addresses

• Strategic intelligence on surgical tourniquet demand across application, product type, end user, technology, and cuff type segments covering orthopedic, trauma, plastic surgery, and ambulatory surgical center applications globally.
• Market forecast from USD 0.8 billion in 2026 to USD 1.9 billion by 2036 at a CAGR of 9.8% with absolute dollar opportunity assessment across pneumatic, electronic, and disposable platform categories.
• Growth opportunity mapping across South Korea National Health Insurance orthopedic reimbursement expansion, US CMS ambulatory surgical center orthopedic procedure approvals, Germany DRG surgical equipment investment cycles, France HAS outpatient reimbursement extensions, and UK NHS Elective Recovery Programme orthopedic volume restoration.
• Segment analysis by application, product, end user, technology, and cuff type with global and regional CAGR forecasts and leading sub-segment share benchmarks for 2026.
• Regional outlook covering North America group purchasing organization contract dynamics, Europe MDR compliance-driven disposable adoption, Asia Pacific national health insurance reimbursement expansion, and emerging market hospital infrastructure investment.
• Competitive analysis of Zimmer Biomet, Stryker Corporation, Delfi Medical Innovations, Anetic Aid, and VBM Medizintechnik covering console platform certification status, disposable cuff compatibility breadth, hospital system contract coverage, and clinical application specialization.
• Regulatory impact analysis covering Joint Commission infection prevention standard updates, CMS ambulatory surgical center orthopedic procedure approvals, EU Medical Device Regulation reusable device audit requirements, and NHS Supply Chain framework contract listing updates.
• Report delivered in PDF, Excel, and presentation formats supported by orthopedic procedure volume data, hospital capital equipment investment benchmarks, and primary interviews with orthopedic surgery department directors and hospital group purchasing organization managers.

Surgical Tourniquets Market Definition

The surgical tourniquets market covers devices applied to limbs to restrict blood flow during operative procedures. These instruments allow surgeons to operate in a bloodless field, reducing intraoperative blood loss and improving visualization across orthopedic, plastic, and trauma surgeries.

Surgical Tourniquets Market Inclusions

The study covers global and regional forecasts from 2026 to 2036 across application, product type, end user, technology, and cuff type. It includes pneumatic, automated electronic, and manual tourniquet systems used in knee arthroplasty, limb amputation, plastic surgery, and trauma case procedures across hospitals, ambulatory surgical centers, and specialized clinics.

Surgical Tourniquets Market Exclusions

The study excludes military-use tactical field tourniquets not configured for sterile operating room environments. It omits tourniquet training simulators and educational equipment. Compression bandages and non-pneumatic limb compression devices used outside surgical settings fall outside study scope.

Surgical Tourniquets Market Research Methodology

• Primary Research
  • Primary research includes interviews with orthopedic surgery department heads at tertiary care hospitals and ambulatory surgical center operations directors. Medical device managers at hospital group purchasing organizations and surgical tourniquet product specialists at leading manufacturers are also covered.
• Desk Research
  • Desk research uses public disclosures from Zimmer Biomet, Stryker Corporation, and Delfi Medical Innovations. It includes CMS hospital outpatient payment rule updates, FDA 510(k) clearance databases for tourniquet devices, and national health technology assessment reports covering 2024 and 2025.
• Market-Sizing and Forecasting
  • Market sizing applies a hybrid top-down and bottom-up model. Orthopedic surgical procedure volume data and device contract values across hospital networks form the base inputs. Segment forecasts are built separately for pneumatic and electronic tourniquet platforms across application and end-user categories.
• Data Validation and Update Cycle
  • Data validation uses surgical tourniquet manufacturer revenue disclosures and hospital capital equipment investment benchmarks validated against 2024 and 2025 company filings. Findings are cross-checked through interviews with orthopedic implant surgery clinical specialists and hospital value analysis committee directors.